RISK MANAGEMENT STRATEGIES FOR REDUCING ORAL ADVERSE DRUG EVENTS

被引:5
|
作者
Spolarich, Ann Eshenaur [1 ,2 ]
机构
[1] USC, Div Dent Publ Hlth & Pediat Dent, Ostrow Sch Dent, Los Angeles, CA 90089 USA
[2] USC, Natl Ctr Dent Hyg Res & Practice, Ostrow Sch Dent, Los Angeles, CA 90089 USA
关键词
Oral adverse drug events; xerostomia; drug-induced ulceration; mucositis; lichenoid drug reaction; CLINICAL-PRACTICE GUIDELINES; SALIVARY-GLANDS; ANTIMICROBIALS; AGENTS;
D O I
10.1016/j.jebdp.2014.04.009
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Oral adverse drug effects negatively impact oral health, comfort and function. Background Patients treated in the oral health care environment take multiple medications, many of which cause oral complications. Dental professionals are challenged with making recommendations to prevent or minimize drug-induced oral disease risks, while reducing symptoms to improve oral health quality of life. Methods This paper presents a critical analysis of current evidence regarding common oral adverse drug events, and reviews existing clinical practice guidelines based upon findings from published systematic reviews. Results There is a lack of sufficient, high quality evidence to support most recommendations for interventions to relieve signs and symptoms of drug-induced oral adverse events. Existing recommendations are largely based on data obtained from observational studies and case reports, and from randomized controlled clinical trials with significant design flaws and potential reporting bias. Outcome measures, especially those related to symptom relief and long-range benefits, are either insufficient or lacking. Conclusions Oral adverse drug effects are a common problem, and additional data is needed to support best practices for product recommendations to improve oral health in medicated patients.
引用
收藏
页码:87 / +
页数:9
相关论文
共 50 条
  • [31] Strategies for improving the management of immune-related adverse events
    Naing, Aung
    Hajjar, Joud
    Gulley, James L.
    Atkins, Michael B.
    Ciliberto, Gennaro
    Meric-Bernstam, Funda
    Hwu, Patrick
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [32] Evolving management strategies in gastrointestinal immunotherapy related adverse events
    Kerkham, Alice
    Win, Su
    Mousa, Salayman
    Chan, Calvin
    Park, John
    Chang, Jeff
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 45 - 45
  • [34] Understanding and reducing the risk of adverse drug reactions in pediatric patients
    Gotta, Verena
    van den Anker, Johannes
    Pfister, Marc
    THERAPEUTISCHE UMSCHAU, 2015, 72 (11-12) : 679 - 686
  • [35] In vitro cytokine release assays: reducing the risk of adverse events in man
    Kirton, Christopher M.
    Gliddon, Daniel R.
    Bannish, Gregory
    Bembridge, Gary P.
    Coney, Lee A.
    BIOANALYSIS, 2011, 3 (23) : 2657 - 2663
  • [36] Risk and management of adverse events in minimally invasive esophagectomy
    Li, Li-Qun
    Jiao, Yan
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2025, 17 (03):
  • [37] Prevention strategies for medication errors and adverse drug events in pediatric inpatients
    Fortescue, EB
    Kaushal, R
    Goldmann, DA
    Bates, DW
    PEDIATRIC RESEARCH, 2002, 51 (04) : 148A - 148A
  • [38] An RFId Smart Container to Perform Drugs Administration Reducing Adverse Drug Events
    Iadanza, E.
    Baroncelli, L.
    Manetti, A.
    Dori, F.
    Miniati, R.
    Gentili, G. Biffi
    5TH EUROPEAN CONFERENCE OF THE INTERNATIONAL FEDERATION FOR MEDICAL AND BIOLOGICAL ENGINEERING, PTS 1 AND 2, 2012, 37 : 679 - 682
  • [39] Association of Pharmacist Interventions With Adverse Drug Events and Potential Adverse Drug Events
    Kelly, W. N.
    Ho, M. J.
    Smith, T.
    Bullers, K.
    Bates, D. W.
    Kumar, A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (07)
  • [40] INCIDENCE OF ADVERSE DRUG EVENTS AND POTENTIAL ADVERSE DRUG EVENTS - IMPLICATIONS FOR PREVENTION
    BATES, DW
    CULLEN, DJ
    LAIRD, N
    PETERSEN, LA
    SMALL, SD
    SERVI, D
    LAFFEL, G
    SWEITZER, BJ
    SHEA, BF
    HALLISEY, R
    VANDERVLIET, M
    NEMESKAL, R
    LEAPE, LL
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (01): : 29 - 34